Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Oct 2;108(10):2052–2060. doi: 10.1111/cas.13329

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

PMC Copyright notice

Detection of serum leucine‐rich α2‐glycoprotein‐1 (LRG1) using ELISA. Serum LRG1 concentrations in 184 patients with gastric cancer and 53 healthy volunteers. Dotted lines show the cut‐off value for LRG1 (19.1 μg/mL). (a) Mean LRG1 concentration for patients with gastric cancer was significantly higher than for healthy volunteers (P < 0.0001). (b) Mean LRG1 concentration increased with the progression of pathological stage. A significant difference was observed between stage I and stage III and between stage I and stage IV disease (P < 0.01). (c) Mean serum LRG1 concentration increased with the progression of the immunohistochemical staining (IHC) scores. (d) IHC results indicate a significant correlation between the serum LRG1 level and LRG1 expression (P < 0.0001).